Impact of the COVID-19 pandemic on the implementation of mobile health to improve the uptake of hydroxyurea in patients with sickle cell disease: Mixed methods study
JMIR Formative Research
Open Access Publication
Rights and Permissions
Badawy SM, DiMartino L, Brambilla D, Klesges L, Baumann A, Burns E, DeMartino T, Jacobs S, Khan H, Nwosu C, Shah N, Hankins JS; Sickle Cell Disease Implementation Consortium. Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study. JMIR Form Res. 2022 Oct 14;6(10):e41415. doi: 10.2196/41415. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.
Badawy, Sherif M; DiMartino, Lisa; Brambilla, Donald; Klesges, Lisa; Baumann, Ana; Burns, Ebony; DeMartino, Terri; Jacobs, Sara; Khan, Hamda; Nwosu, Chinonyelum; Shah, Nirmish; Hankins, Jane S; and Sickle Cell Disease Implementation Consortium, "Impact of the COVID-19 pandemic on the implementation of mobile health to improve the uptake of hydroxyurea in patients with sickle cell disease: Mixed methods study." JMIR Formative Research. 6, 10. e41415 (2022).
Supplemental material is available for this article at publisher site.